Key result
Proton pump inhibitors linked to ~/dL lower serum magnesium versus non-users in dialysis patients.
Why the study?
Does discontinuation of esomeprazole improve serum magnesium levels in a hemodialysis patient with hypomagnesemia?
Observational (n=531)
Does discontinuation of esomeprazole improve serum magnesium levels in a hemodialysis patient with hypomagnesemia?
Discontinuation of proton pump inhibitors rapidly resolves hypomagnesemia in hemodialysis patients, highlighting the importance of regular magnesium monitoring in this population.
Answers are grounded in this paper and cite their sources.
May warrant PPI deprescribing in hemodialysis patients with hypomagnesemia; reinforces prior evidence and supports routine magnesium monitoring.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Higuchi et al. (2026) conducted an observational in Dialysis patients with end-stage renal disease (n=531). Proton pump inhibitors (PPI) use vs. No PPI use was evaluated on Prevalence of hypomagnesemia induced by proton pump inhibitors. Proton pump inhibitors were associated with lower serum magnesium levels compared to non-PPI users in dialysis patients, indicating PPI-induced hypomagnesemia.
Synapse has enriched 10 related papers. Consider them for comparative context: